Topic List : Cancer
Cancer Institute symposium to feature young researchers
Stanford graduate students, postdoctoral scholars and other junior investigators will convene Feb. 23 share their latest research projects and hear advice from established cancer scientists.
When Breath Becomes Air: A conversation with Lucy Kalanithi, MD
In this podcast, Lucy Kalanithi, MD, talks about the words that her late husband, Stanford neurosurgeon Paul Kalanithi, left behind -- a new book entitled, “When Breath Becomes Air."…
Chemotherapy may benefit subgroup of stage-2 colon cancer patients
A small subset of colon cancers lacks the CDX2 protein — a hallmark of colon tissue maturation. Patients with these cancers may benefit more than others from chemotherapy.
Expert in cancer immunotherapy joins Stanford Medicine faculty
Crystal Mackall will lead the university’s efforts to translate basic science discoveries into immune-based treatments for pediatric and adult cancers.
New microscopy technique maps mechanical properties of living cells
Researchers have developed a new way to use atomic force microscopy to rapidly measure the mechanical properties of cells, an advance that could pave the way for better understanding immune disorders and cancer.
SRI Biosciences, Stanford Cancer Institute launch drug discovery program
The SRI Biosciences-Stanford Drug Discovery and Development Program was created in response to a significant drop in the early pipeline of innovative new drugs.
Common treatment for prostate cancer appears to double Alzheimer’s risk
Short-circuiting the need for expensive clinical trials, researchers uncovered an association between androgen blockers and cognitive decline by examining patient medical records.
New class of RNA tumor suppressors identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Researchers receive outstanding investigator awards from National Cancer Institute
Steven Artandi, Laura Attardi and Amato Giaccia will receive up to $600,000 annually for seven years to study cancer processes.
Story of family's tumor donation inspires more donations
With the donated tissue, a Stanford team has created the first cell line and mouse model of diffuse intrinsic pontine glioma, a deadly tumor.